455 results on '"Elmaagacli, A H"'
Search Results
2. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
3. Progressive Improvement in Cutaneous and Extracutaneous Chronic Graft-versus-Host Disease after a 24-Week Course of Extracorporeal Photopheresis—Results of a Crossover Randomized Study
4. Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells
5. Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD
6. Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight—new perspectives?
7. Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors
8. Retrospective analysis of treosulfan-based conditioning in comparison with standard conditioning in patients with myelodysplastic syndrome
9. Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9
10. PROSPECTIVE STUDY OF 46 GENE VARIANTS INFLUENCED CLINICAL OUTCOME FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: PH-AB243
11. MIRNA BIOMARKER OF CLINICAL OUTCOME IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: PH-AB108
12. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation
13. Gene profiling of growth factor independence 1B gene (Gfi-1B) in leukemic cells
14. Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation
15. Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia
16. Molecular Methods Used for Detection of Minimal Residual Disease Following Hematopoietic Stem Cell Transplantation in Myeloid Disorders
17. Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation
18. Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia
19. Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
20. Increased susceptibility for aspergillosis and post-transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantation
21. Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells
22. Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological non-mast cell lineage disease after allogeneic transplantation
23. Disease characteristics and new clinical approaches in bronchiolitis obliterans (BO) after allogeneic haematopoietic stem cell transplantation (HSCT): O374
24. DIPSS-plus improves outcome prediction after allogeneic haematopoietic stem cell transplantation (HSCT) for myelofibrosis: O152
25. Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients
26. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage
27. Clinical course and molecular features in 21 patients with atypical chronic myeloid leukemia
28. Therapeutic Targeting of Gene Expression by siRNAs Directed Against BCR-ABL Transcripts in a Patient with Imatinib-Resistant Chronic Myeloid Leukemia
29. Significance of prognostic scores, risk factors and chronic graft-versus-host-disease (cGVHD) on outcome after allogeneic haematopoietic stem cell transplantation (HSCT) for myelofibrosis: V697
30. Chronic GvHD is the most pivotal factor for improved relapse-free survival in patients with myelofibrosis after myeloablative allogeneic haematopoietic stem cell transplantation: P1149
31. Improved outcome of transplant in patients with CML: P1148
32. Oxidative stress induced by small interfering RNA against glutathione reductase transcripts sensitizes mutated T315I cells to nilotinib: P1157
33. Increased miRNA17 and miRNA20a expression in patients with development of acute graft-versus-host disease after allogeneic stem cell transplantation: P849
34. P637 Genetic polymorphism of cytochrome P450 1B1 (C432G) is associated with an increased treatment-related mortality and lower overall survival in patients undergoing allogeneic haematopoietic stem cell transplantation
35. Pravastatin after allogeneic haematopoietic stem cell transplantation: better tolerated than expected but without significant influence on chronic graft-versus-host disease: P494
36. Early CMV-replication after allogeneic stem cell transplantation is associated with a dramatically reduced relapse risk in acute myeloid leukaemia patients: evidence for a putative virus-versus-leukaemia effect: O312
37. Results of simultaneous analysis of 48 gene variants reported to have influence on transplant outcome: O392
38. H1N1 in allogeneic stem cell recipients: courses of infection and influence of vaccination on graft-versus-host-disease (GVHD)
39. Interrelation of 5q-Deletions and Mutations of TP53 in Patients with Myelodysplastic Syndromes and Complex Aberrations
40. Molecular Methods Used for Detection of Minimal Residual Disease Following Hematopoietic Stem Cell Transplantation in Myeloid Disorders
41. Improved outcome of transplant in patients with CML: V280
42. Genetic polymorphism of cytochrome P450 1B1 (C432G) is associated with an increased treatment-related mortality and lower overall survival in patients undergoing allogeneic hematopoietic stem cell transplantation: V664
43. Cytomegalovirus reduces the relapse risk for acute leukemia after transplant: there is a virus-versus-leukemia effect: V643
44. TLR9 but not NOD2/CARD15 gene polymorphism influence outcome in AML-patients transplanted from HLA-identical sibling donors: V642
45. TLR9 but not NOD2/CARD15 gene polymorphism influenced outcome in AML-patients transplanted from HLA-identical sibling donors: O407
46. Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias
47. Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia
48. Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate
49. Quantitative Analysis of Chimerism after Allogeneic Stem Cell Transplantation by Real-Time Polymerase Chain Reaction with Single Nucleotide Polymorphisms, Standard Tandem Repeats, and Y-Chromosome-Specific Sequences
50. Myeloablative allogeneic hematopoietic stem cell transplantation in elderly patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.